Presented by the Northwestern University Feinberg School of Medicine
MULTIPLE SCLEROSIS VIRTUAL EDUCATION SERIES
Advances in the Assessment and Management of Multiple Sclerosis
Live! Complimentary, Online Continuing Medical Education
Watch top neurologists – live and online – discuss the latest scientific research via live streaming video, participate in real-time Q and A online and earn AMA PRA Category 1 CreditsTM. Topics include: New Disease-Modifying Therapies, Insights from AAN, Improved Adherence to Treatment and Quality of Life.
Join us on Tuesday, August 13, 2013 at 10:00 AM – 12:00 PM Eastern
REGISTER Today – It’s free to join.
www.neuroserieslive.com/en_CA/br/MultipleSclerosis/refcode=ConfrAlerts-Email-MS-081313
The Multiple Sclerosis Virtual Education Series is an online event that includes all of the features of a live medical conference, including streaming video lectures, panel discussions and case presentations as well as interactive activities such as real-time question and answer sessions with top faculty and other participants.
ACTIVITY CHAIR
Bruce A. Cohen, MD
Professor of Neurology
Northwestern University Feinberg School of Medicine
Each session has been approved for 1.0 AMA PRA Category 1 CreditsTM.
Advances in the Assessment and Management of Multiple Sclerosis
Tuesday, August 13, 2013 at 10:00 AM – 12:00 PM Eastern
TUESDAY, AUGUST 13, 2013
11:00 AM
The Changing Landscape of Multiple Sclerosis (MS): Emerging Disease-Modifying Therapies
– Bruce A. Cohen, MD, Northwestern University Feinberg School of Medicine
12:00 PM
Disease-modifying MS Therapies in Clinical Practice: Which Therapies for Which Patients?
– Fred Lublin, MD, Icahn School of Medicine at Mount Sinai
WEDNESDAY, SEPTEMBER 25, 2013
10:00 AM
Differential Diagnosis of Multiple Sclerosis: Tips from the Experts
– Aaron Miller, MD, Mount Sinai Hospital
11:00 AM
The Potential Role of Biomarkers in Diagnosing and Managing MS
– Suhayl Dhib-Jalbut, MD, Robert Wood Johnson University Hospital
TUESDAY, NOVEMBER 19, 2013
10:00 AM
Maximizing Adherence to Disease-Modifying Therapies in Patients with MS
– Bruce A. Cohen, MD, Northwestern University Feinberg School of Medicine
11:00 AM
Strategies for Optimizing Function and Quality of Life in MS
Each session has been approved for 1.0 AMA PRA Category 1 CreditTM.
ACKNOWLEDGEMENT
This activity is supported by educational grants from TEVA Pharmaceuticals, and EMD Serono, Inc.
TUITION
Complimentary
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Northwestern University Feinberg School of Medicine and PlatformQ LLC. Northwestern University Feinberg School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
Live Activity
The Northwestern University Feinberg School of Medicine designates this educational activity for a maximum of 6.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enduring Materials
The Northwestern University Feinberg School of Medicine designates these enduring materials for a maximum of 6.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Physician assistants may receive a maximum of 6.0 hours of credit for completing these programs.
DATE OF RELEASE/EXPIRATION
– Thursday, July 18, 2013; 10:00 AM – 12:00 PM ET
– Wednesday, September 25, 2013; 10:00 AM – 12:00 PM ET
– Tuesday, November 19, 2013; 10:00 AM – 12:00 PM ET
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
– Assess and apply recent clinical guidelines, emerging evidence, and current expert opinion to improve the differential diagnosis of multiple sclerosis (MS)
– Choose among currently approved disease-modifying therapies for MS patients based on patient characteristics and recent clinical evidence, and outline the potential role of novel therapies currently in development
– Understand the significance and utility of emerging diagnostic and prognostic biomarkers for MS in order to appropriately apply them in clinical practice
– Identify common reasons for suboptimal patient adherence to disease-modifying therapies and apply strategies to improve adherence to treatment
– Develop evidence-based, expert-driven management plans for MS symptoms that improve functional abilities and quality of life for patients with MS
INTENDED AUDIENCE
The summit is planned to meet the continuing medical education needs of neurologists involved in the diagnosis, treatment and ongoing management of patients with MS. Additionally, general neurologists, internists, family physicians, nurse practitioners, physician assistants, and pharmacists who are actively engaged in the care of patients with MS may also benefit from participating in the program as secondary audiences.
ESTIMATED TIME TO COMPLETE
The activity consists of four sessions, which should take approximately 6.0 hours to complete.
METHOD OF PARTICIPATION
There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimate that each module will take approximately 1 hour to complete. To receive AMA PRA Category 1 CreditTM, participants must receive a minimum score of 70 percent on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FACULTY DISCLOSURE
In accordance with ACCME Standards for Commercial Support of Continuing Medical Education and the Feinberg School of Medicine’s (FSM) disclosure policy for CME activities, all individuals who contribute to the content or the identification / resolution of potential conflicts of interest must disclose any relationship they may have with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients within the preceding 12 months of the activity. Such disclosure is intended to provide participants with sufficient information to evaluate whether any given presentation has been influence by the faculty’s relationships(s) or financial interest with said companies. The course director and presenter’s disclosure information will be communicated to the audience at the being of each presentation.
FSM’s CME LEADERSHIP
John X. Thomas, Jr., PhD, Sr. Associate Dean for Medical Education
Has nothing to disclose.
Genevieve Napier, CME Director
Has nothing to disclose.
Jennifer Banys , Ashley Kick and Tara Scavelli, CME Project Specialists
Have nothing to disclose.
PlatformQ Health, Inc
Alyce Kuklinski, NP, RN, Senior Medical Director
Has nothing to disclose.
CONTACT INFORMATION
Please send all inquiries to: Northwestern University Feinberg School of Medicine, Office of Continuing Medical Education, by phone: 312-503-8533 or email: nums-cme@northwestern.edu.
Enquiries: mabber@platformq.com
Web address: http://www.neuroserieslive.com/en_CA/br/MultipleSclerosis/refcode=ConfrAlerts-List-MS-081313
Sponsored by: Northwestern University Feinberg School of Medicine